Trials / Withdrawn
WithdrawnNCT01496209
REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Cedars-Sinai Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A double blinded and placebo-controlled, dose escalation, single-center safety and preliminary efficacy study of cardiospheres delivered via NOGA MYOSTAR injection catheter in subjects with chronic ischemic cardiomyopathy. The objective is to achieve and document myocardial regeneration in patients with chronic scar.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Endomyocardial injections of allogeneic Human CSps | NOGA electromechanical mapping and endomyocardial injections at 15 peri-infarct sites, via NOGA MYOSTAR catheter, of Allogeneic Human CSps. |
| BIOLOGICAL | Endomyocardial injections of vehicle only. | NOGA electromechanical mapping and endomyocardial injections at 15 peri-infarct sites, via NOGA MYOSTAR catheter, of placebo. |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2011-12-21
- Last updated
- 2014-02-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01496209. Inclusion in this directory is not an endorsement.